Literature DB >> 3499374

Distribution of alpha-1-antitrypsin and haptoglobin phenotypes in bladder cancer patients.

H G Benkmann1, H P Hanssen, R Ovenbeck, H W Goedde.   

Abstract

Frequencies of the alpha 1-antitrypsin (Pi) alleles and haptoglobin phenotypes have been determined in a series of 264 North-German patients with bladder cancer. Compared to a healthy control population, we found a statistically significant decrease of Hp 2-2 phenotype in the patient series. A significant increase of the serum Pi Z allele, as previously shown for patient groups with certain other tumours, could also be confirmed for bladder cancer. Furthermore, a distinct association between a lowered M 3 allele and bladder carcinoma was observed.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3499374     DOI： 10.1159/000153720

Source DB:  PubMed          Journal:  Hum Hered        ISSN： 0001-5652            Impact factor:   0.444


  9 in total

1.  Haptoglobin is a serological biomarker for adenocarcinoma lung cancer by using the ProteomeLab PF2D combined with mass spectrometry.

Authors:  You-Kang Chang; Yu-Heng Lai; Yen Chu; Ming-Cheng Lee; Chun-Yao Huang; Semon Wu
Journal:  Am J Cancer Res       Date:  2016-08-01       Impact factor: 6.166

2.  Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer.

Authors:  Changqing Zhao; Loganath Annamalai; Changfa Guo; Narasimhan Kothandaraman; Stephen Chee Liang Koh; Huoming Zhang; Arijit Biswas; Mahesh Choolani
Journal:  Neoplasia       Date:  2007-01       Impact factor: 5.715

3.  Potential biomarkers in the sera of breast cancer patients from bahawalpur, pakistan.

Authors:  Faiz-Ul-Hassan Nasim; Samina Ejaz; Muhammad Ashraf; Abdul Rehman Asif; Michael Oellerich; Gulzar Ahmad; Gulzar Ahmad Malik
Journal:  Biomark Cancer       Date:  2012-12-10

4.  Polymorphism of alpha-1-antitrypsin in hematological malignancies.

Authors:  Aleksandra Topic; Zorica Juranic; Svetislav Jelic; Ivana Golubicic Magazinovic
Journal:  Genet Mol Biol       Date:  2009-12-01       Impact factor: 1.771

5.  Lung cancer proteomics: recent advances in biomarker discovery.

Authors:  Paola Indovina; Eleonora Marcelli; Pasquale Maranta; Giulio Tarro
Journal:  Int J Proteomics       Date:  2011-09-15

6.  Identification of 10 Candidate Biomarkers Distinguishing Tuberculous and Malignant Pleural Fluid by Proteomic Methods.

Authors:  Chang Youl Lee; Ji Young Hong; Myung Goo Lee; In Bum Suh
Journal:  Yonsei Med J       Date:  2017-11       Impact factor: 2.759

7.  Proteomic identification of fucosylated haptoglobin alpha isoforms in ascitic fluids and its localization in ovarian carcinoma tissues from Mexican patients.

Authors:  Olga Lilia Garibay-Cerdenares; Verónica Ivonne Hernández-Ramírez; Juan Carlos Osorio-Trujillo; Magdalena Hernández-Ortíz; Dolores Gallardo-Rincón; David Cantú de León; Sergio Encarnación-Guevara; Julio César Villegas-Pineda; Patricia Talamás-Rohana
Journal:  J Ovarian Res       Date:  2014-02-27       Impact factor: 4.234

8.  Serum concentration of alpha-1 antitrypsin is significantly higher in colorectal cancer patients than in healthy controls.

Authors:  Sergio Pérez-Holanda; Ignacio Blanco; Manuel Menéndez; Luis Rodrigo
Journal:  BMC Cancer       Date:  2014-05-21       Impact factor: 4.430

9.  Haptoglobin and CCR2 receptor expression in ovarian cancer cells that were exposed to ascitic fluid: exploring a new role of haptoglobin in the tumoral microenvironment.

Authors:  O L Garibay-Cerdenares; V I Hernández-Ramírez; J C Osorio-Trujillo; D Gallardo-Rincón; P Talamás-Rohana
Journal:  Cell Adh Migr       Date:  2015-07-25       Impact factor: 3.405
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.